Fuso Pharmaceutical IndustriesFuso Pharmaceutical Industries,Ltd.4538東証プライム医薬品FY ending Mar 2026, non-consolidated, J-GAAP

What does Fuso Pharmaceutical Industries do with its cash?

How cash from operations was spent on investment, dividends, buybacks and more.

※ Operating cash flow is negative

Operating cash flow
-¥6.22B
Capex
¥1.66B
of revenue 2.7%
Free cash flow
-¥7.88B
Returned to shareholders
¥736M
of net income: 37%
Dividend per share
¥90
Payout ratio (reported)
38.2%

Cash flow ratios

Cash conversion, investment and shareholder payments calculated from disclosed figures.

Net income¥2.01B
Operating cash flow-¥6.22B
Cash conversion (operating CF ÷ operating income)
-235.8%
Cash vs. profit gap
-¥8.23B(純利益の -409.5%)
Shareholder returns
of net income 36.6%
Shareholder payments — dividends
of net income 36.5%
CapEx intensity (capex ÷ revenue)
2.7%

Nonpositive profit and free cash flow are omitted as ratio denominators. Amounts use the period's reported currency.

Five-year trend

Operating cash flow-¥6.22B
FY ending Mar 2022: ¥3.5B¥3.5BFY ending Mar 2023: ¥2.85B¥2.85BFY ending Mar 2024: ¥627M¥627MFY ending Mar 2025: -¥3.31B-¥3.31BFY ending Mar 2026: -¥6.22B-¥6.22BFY22FY23FY24FY25FY26
Free cash flow-¥7.88B
FY ending Mar 2022: ¥2.01B¥2.01BFY ending Mar 2023: ¥1.28B¥1.28BFY ending Mar 2024: -¥2.96B-¥2.96BFY ending Mar 2025: -¥6.4B-¥6.4BFY ending Mar 2026: -¥7.88B-¥7.88BFY22FY23FY24FY25FY26
Net income¥2.01B
FY ending Mar 2022: ¥1.48B¥1.48BFY ending Mar 2023: ¥1.6B¥1.6BFY ending Mar 2024: ¥1.38B¥1.38BFY ending Mar 2025: -¥3.29B-¥3.29BFY ending Mar 2026: ¥2.01B¥2.01BFY22FY23FY24FY25FY26

How to read this

  • Operating cash flow is the cash the core business actually brought in, including changes in receivables and inventory.
  • Free cash flow = operating cash flow − capital expenditure: a gauge of cash available for other uses.
  • Large "borrowing" or "cash drawdown" flows mean the company spent more than it generated that year.

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第103期(2025/04/01-2026/03/31)

    ID S100YHSC2026-06-23Open
  • EDINET (FSA Japan)

    有価証券報告書-第102期(2024/04/01-2025/03/31)

    ID S100W3Q02025-06-24Open
  • EDINET (FSA Japan)

    有価証券報告書-第101期(2023/04/01-2024/03/31)

    ID S100TRL62024-06-25Open
  • EDINET (FSA Japan)

    有価証券報告書-第100期(2022/04/01-2023/03/31)

    ID S100R6DG2023-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第99期(令和3年4月1日-令和4年3月31日)

    ID S100OL982022-06-29Open
  • EDINET (FSA Japan)

    有価証券報告書-第98期(令和2年4月1日-令和3年3月31日)

    ID S100LSH72021-06-29Open

Extracted from XBRL: 50 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.